Article ID Journal Published Year Pages File Type
3361578 International Journal of Infectious Diseases 2016 4 Pages PDF
Abstract

•Consecutive patients (n = 2435) with invasive pneumococcal disease (IPD) were collected prospectively; 37 (1.5%) were asplenic.•Asplenic patients had a more severe infection (e.g., need for mechanical ventilation, intensive care unit admission) and more complications (e.g., meningitis, acute kidney injury).•However, the in-hospital mortality rate of 19% for those without a spleen was not significantly higher than that of 16% for those who had a spleen.•Pneumococcal serotype 22B accounted for 27% of the isolates amongst the asplenic patients and this was 33-fold higher than the rate in the patients with a spleen.

SummaryObjectivesMost are aware of pneumococcal infection as a complication of splenectomy and the increased risk of severe invasive pneumococcal disease (IPD) in asplenic patients. However little is known of the current status of this entity in a population with an active pneumococcal conjugate vaccine program for children.MethodsAll IPD cases reported from 2000 to 2014 in Northern Alberta, Canada were collected prospectively. Socio-demographic variables, clinical characteristics, and IPD-related outcomes were compared between patients with and without a spleen using the Student t-test, Chi-square test, or Fisher's exact test, as appropriate.ResultsThirty-seven of 2435 patients with IPD (1.5%) were asplenic. Asplenic patients were significantly more likely to require mechanical ventilation or admission to the intensive care unit and had more complications (e.g., acute kidney injury). However, in-hospital mortality rates were similar in those with and without a spleen (19% vs. 16%, p = 0.58). Pneumococcal serotype 22B was 33-fold higher in asplenic patients compared to those with a spleen.ConclusionsIn patients with IPD, those who are asplenic have a more severe infection than those with a spleen; however, the mortality rate is not significantly different. The reason for the predominance of serotype 22B requires further investigation and if replicated may warrant attention to current vaccination strategies.

Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Authors
, , , ,